Lactylation as a potential epigenetic and metabolic modulator of cuproptosis in health and disease: Current evidence and hypotheses.

Zhang Z, Pan L, Li D, Xiao D

Open source

DOI
10.1016/j.biopha.2026.119981
Published
2026 Nov
Container
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.biopha.2026.119981,
  title = {Lactylation as a potential epigenetic and metabolic modulator of cuproptosis in health and disease: Current evidence and hypotheses.},
  author = {Zhang Z and Pan L and Li D and Xiao D},
  year = {2026},
  journal = {Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie},
  doi = {10.1016/j.biopha.2026.119981},
  url = {https://doi.org/10.1016/j.biopha.2026.119981}
}

RIS

TY  - JOUR
TI  - Lactylation as a potential epigenetic and metabolic modulator of cuproptosis in health and disease: Current evidence and hypotheses.
AU  - Zhang Z
AU  - Pan L
AU  - Li D
AU  - Xiao D
PY  - 2026
JO  - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
DO  - 10.1016/j.biopha.2026.119981
UR  - https://doi.org/10.1016/j.biopha.2026.119981
ER  - 

APA

Z, Z., L, P., D, L., & D, X. (2026). Lactylation as a potential epigenetic and metabolic modulator of cuproptosis in health and disease: Current evidence and hypotheses.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. https://doi.org/10.1016/j.biopha.2026.119981

Source records